IL24 and neoplasm: The efficacy of MDA-7/IL-24 as a cancer therapeutic has been established in pre-clinical studies using multiple tumor models, including nude mice, syngeneic mice and transgenic animals [6,7,16,17,18,19,20,21,55,65].